Unknown

Dataset Information

0

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.


ABSTRACT: Previous studies have demonstrated that serological markers can assist in diagnosing inflammatory bowel disease (IBD). In this study, we aim to build a diagnostic tool incorporating serological markers, genetic variants, and markers of inflammation into a computational algorithm to examine patterns of combinations of markers to (1) identify patients with IBD and (2) differentiate patients with Crohn's disease (CD) from ulcerative colitis (UC).In this cross-sectional study, patient blood samples from 572 CD, 328 UC, 437 non-IBD controls, and 183 healthy controls from academic and community centers were analyzed for 17 markers: 8 serological markers (ASCA-IgA, ASCA-IgG, ANCA, pANCA, OmpC, CBir1, A4-Fla2, and FlaX), 4 genetic markers (ATG16L1, NKX2-3, ECM1, and STAT3), and 5 inflammatory markers (CRP, SAA, ICAM-1, VCAM-1, and VEGF). A diagnostic Random Forest algorithm was constructed to classify IBD, CD, and UC.Receiver operating characteristic analysis compared the diagnostic accuracy of using a panel of serological markers only (ASCA-IgA, ASCA-IgG, ANCA, pANCA, OmpC, and CBir1) versus using a marker panel that in addition to the serological markers mentioned above also included gene variants, inflammatory markers, and 2 additional serological markers (A4-Fla2 and FlaX). The extended marker panel increased the IBD versus non-IBD discrimination area under the curve from 0.80 (95% confidence interval [CI], ±0.05) to 0.87 (95% CI, ±0.04; P < 0.001). The CD versus UC discrimination increased from 0.78 (95% CI, ±0.06) to 0.93 (95% CI, ±0.04; P < 0.001).Incorporating a combination of serological, genetic, and inflammation markers into a diagnostic algorithm improved the accuracy of identifying IBD and differentiating CD from UC versus using serological markers alone.

SUBMITTER: Plevy S 

PROVIDER: S-EPMC3792797 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.

Plevy Scott S   Silverberg Mark S MS   Lockton Steve S   Stockfisch Tom T   Croner Lisa L   Stachelski Jordan J   Brown Michelle M   Triggs Cheryl C   Chuang Emil E   Princen Fred F   Singh Sharat S  

Inflammatory bowel diseases 20130501 6


<h4>Background</h4>Previous studies have demonstrated that serological markers can assist in diagnosing inflammatory bowel disease (IBD). In this study, we aim to build a diagnostic tool incorporating serological markers, genetic variants, and markers of inflammation into a computational algorithm to examine patterns of combinations of markers to (1) identify patients with IBD and (2) differentiate patients with Crohn's disease (CD) from ulcerative colitis (UC).<h4>Methods</h4>In this cross-sect  ...[more]

Similar Datasets

| S-EPMC4335694 | biostudies-literature
| S-EPMC7502466 | biostudies-literature
| S-EPMC5858028 | biostudies-literature
| S-EPMC4714968 | biostudies-literature
| S-EPMC7409252 | biostudies-literature
| S-EPMC9572110 | biostudies-literature
| S-EPMC3164287 | biostudies-literature
| S-EPMC6930002 | biostudies-literature
| S-EPMC10385744 | biostudies-literature
| S-EPMC5874003 | biostudies-literature